Showing results (201-210 of 219) with videos related to
Sort By:
Pageof 22
Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association|June 27, 2014
The empirical foundations of telemedicine interventions for chronic disease managementRashid L Bashshur, Gary W Shannon, Brian R Smith, et al.BMJ Open|August 22, 2020
Supporting self-management of low back pain with an internet intervention in primary care: a protocol for a randomised controlled trial of clinical and cost-effectiveness (SupportBack 2)Adam W A Geraghty, Lisa Roberts, Jonathan Hill, et al.Cancer Research|May 3, 2008
ABT-263: a potent and orally bioavailable Bcl-2 family inhibitorChristin Tse, Alexander R Shoemaker, Jessica Adickes, et al.Psychological Medicine|November 27, 2020
Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions' approaches to an evolving healthcare landscapeShotaro Kinoshita, Kelley Cortright, Allison Crawford, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2019
Comparison of Biomarker Assays for EGFR: Implications for Precision Medicine in Patients with GlioblastomaAndrew B Lassman, Lisa Roberts-Rapp, Irina Sokolova, et al.Neuro-Oncology|January 1, 2017
Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastomaDavid A Reardon, Andrew B Lassman, Martin van den Bent, et al.Journal of Neuro-Oncology|July 6, 2019
Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastomaAndrew B Lassman, Kenneth D Aldape, Peter J Ansell, et al.Neuro-Oncology|July 9, 2018
Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trialAndrew B Lassman, Martin J van den Bent, Hui K Gan, et al.Cancer Chemotherapy and Pharmacology|October 28, 2017
Efficacy of depatuxizumab mafodotin (ABT-414) monotherapy in patients with EGFR-amplified, recurrent glioblastoma: results from a multi-center, international studyMartin van den Bent, Hui K Gan, Andrew B Lassman, et al.Ophthalmology|April 17, 2017
Whole-Exome Sequencing Identifies Biallelic IDH3A Variants as a Cause of Retinitis Pigmentosa Accompanied by PseudocolobomaLaurence H M Pierrache, Adva Kimchi, Rinki Ratnapriya, et al.Pageof 22